Patients With Muscle-Invasive Bladder Cancer With Lymphovascular Invasion in Transurethral Resection Specimen Benefits Most From Platinum-Based Neoadjuvant Chemotherapy

淋巴血管侵犯 医学 膀胱切除术 膀胱癌 肿瘤科 队列 比例危险模型 内科学 泌尿科 化疗 癌症 外科 转移
作者
Ziwei Wang,Wei He,Yidie Ying,Maoyu Wang,Qing Chen,Zhensheng Zhang,Shuxiong Zeng,Chuanliang Xu
出处
期刊:Clinical Genitourinary Cancer [Elsevier]
卷期号:22 (2): 201-209.e7
标识
DOI:10.1016/j.clgc.2023.10.014
摘要

The survival benefit of neoadjuvant chemotherapy (NAC) before definitive radical cystectomy (RC) varied among patients, suggesting proper selection of patients for NAC to maximize the survival benefit. This study aimed to investigate the role of lymphovascular invasion (LVI) in transurethral resection (TUR) specimens in selecting patients with MIBC for NAC.Two retrospective cohorts of patients with cT2-4aN0 MIBC who underwent RC from 2004 to 2015 provided by Lund University were included. Inverse probability weighting was applied to make the NAC-treated (NAC) and untreated (non-NAC) cohorts comparable. Survival benefits were estimated with Kaplan-Meier curves and Cox proportional hazards models. The primary endpoint was cancer-specific survival (CSS). LVI in TUR specimens and molecular taxonomies (BASE47, UNC, and LundTax) were examined, and bulk RNA-seq datasets were explored for LVI-relevant signatures.A total of 341 patients with cT2-4aN0 MIBC were included. The NAC cohort included 125 patients, whereas the non-NAC cohort included 216 patients. The 3-year CSS benefit of NAC was 7.1%. For patients with positive LVI in TUR specimens, the 3-year CSS benefit of NAC was 26.2% (48.1% vs. 74.3%), with a risk reduction of 56% (HR = 0.44, P = .03). A sensitivity analysis confirmed a significant interaction between LVI and NAC. This study failed to identify the molecular subtypes that maximized the survival benefit of NAC. Exploration of LVI-relevant signatures remains inconclusive.LVI in TUR specimens could help identify patients with MIBC who would derive maximal survival benefit from NAC. Further prospective validation is necessary.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏应助Refrain采纳,获得20
刚刚
小马甲应助淡水美人鱼采纳,获得20
1秒前
1秒前
morenmoyan发布了新的文献求助10
1秒前
1秒前
wqh关注了科研通微信公众号
1秒前
gggja发布了新的文献求助20
2秒前
NPC发布了新的文献求助50
3秒前
小明发布了新的文献求助20
3秒前
hhhhhhhh发布了新的文献求助10
3秒前
Ganlou应助wewewew采纳,获得10
3秒前
背后的伊发布了新的文献求助10
4秒前
4秒前
郭郭要努力ya完成签到 ,获得积分10
4秒前
Leonardi应助大胆短靴采纳,获得500
4秒前
vane发布了新的文献求助10
4秒前
4秒前
5秒前
5秒前
CodeCraft应助快去睡觉采纳,获得10
5秒前
团子发布了新的文献求助10
5秒前
从容万恶发布了新的文献求助10
5秒前
sss完成签到,获得积分10
6秒前
6秒前
鱼鱼鱼完成签到,获得积分10
6秒前
7秒前
z3Q应助爱炸串的猫采纳,获得10
7秒前
科研通AI2S应助343386625采纳,获得10
7秒前
寒蕾完成签到,获得积分10
8秒前
wudi19887发布了新的文献求助10
8秒前
cabbage008完成签到,获得积分10
8秒前
kqier发布了新的文献求助10
8秒前
9秒前
vane完成签到,获得积分10
9秒前
柳丹秋完成签到,获得积分10
9秒前
FashionBoy应助踏实的翠绿采纳,获得30
9秒前
muzi发布了新的文献求助10
9秒前
10秒前
10秒前
拄着拐棍跳舞完成签到,获得积分10
10秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Near Infrared Spectra of Origin-defined and Real-world Textiles (NIR-SORT): A spectroscopic and materials characterization dataset for known provenance and post-consumer fabrics 610
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3305566
求助须知:如何正确求助?哪些是违规求助? 2939312
关于积分的说明 8492936
捐赠科研通 2613754
什么是DOI,文献DOI怎么找? 1427569
科研通“疑难数据库(出版商)”最低求助积分说明 663115
邀请新用户注册赠送积分活动 647883